1,894 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Philips North America recalled 1,913,441 IntelliVue MX100 patient monitors due to potential alarm failure. The recall is active as of December 2025. The manufacturer warns patients and healthcare providers to stop using affected devices and follow recall instructions. Contact Philips North America LLC for guidance.
Stryker recalled 289 Arise 1000EX mattresses on October 31, 2025. The recall affects products sold nationwide due to potential incompatibility with MV3 beds. Users should stop using these mattresses immediately.
Philips North America is recalling 1,913,441 IntelliVue MP2 patient monitors worldwide. The devices may fail to alarm when critical conditions arise. Hospitals should stop using the monitors and follow Philips recall instructions.
Nivagen Pharmaceuticals recalled 13,536 containers of zinc oxide ointment on October 31, 2025. The recall follows deviations from current Good Manufacturing Practices (cGMP). Consumers must stop using the product immediately and contact healthcare providers for guidance.
Cipla USA recalled 4,438 cartons of Phytonadione Injectable Emulsion on October 31, 2025. The product failed stability specifications, raising concerns about its safety. Consumers and healthcare providers must stop using the product immediately and seek guidance.
Stryker recalled 39,148 NICO BrainPath BrainPath Shephard's Hook devices distributed worldwide through multiple healthcare providers. latex-containing tape in packaging is the defect, despite latex-free labeling. Stop using the device now and follow recall instructions from Stryker or your healthcare provider.
Trifecta Pharmaceuticals recalled 14,700 bottles of Globe Clotrimazole Cream USP on October 31, 2025, due to significant cGMP deviations. The affected product may not meet necessary safety and quality standards. Consumers should stop using the cream immediately and seek guidance from healthcare providers.
Philips North America recalled 1,913,441 IntelliVue MP90 monitors on October 31, 2025. The monitors may fail to alarm, posing a high risk to patient safety. Users must stop using the devices immediately and follow manufacturer instructions for remedy.
Philips North America LLC is recalling 1,913,441 IntelliVue MX700 patient monitors (Product Number 865241) distributed worldwide. The monitors may fail to alarm. Hospitals and clinicians should stop using the affected devices immediately and follow the recall instructions.
Dynarex Corporation recalled 18,912 containers of Wecare Enema on October 31, 2025, due to cGMP deviations. Consumers should stop using the product immediately. The recall affects products distributed nationwide in the USA.
Philips North America LLC recalled 1,913,441 IntelliVue MP80 patient monitors distributed worldwide to hospitals after reports the devices did not alarm. The defect could prevent alarms from sounding in critical patient situations. Healthcare facilities should stop using the monitors and follow recall instructions from the manufacturer.
Philips recalled 1,913,441 IntelliVue MX600 patient monitors distributed worldwide after reports that the devices did not alarm. The defect could prevent alarms that alert clinicians to patient distress. Hospitals and clinicians should stop using the devices immediately and follow the recall instructions from Philips North America LLC.
Philips North America LLC recalled 1,913,441 IntelliVue Multi Measurement Server X2 M3002A monitors sold to hospitals and healthcare facilities worldwide after reports the devices could fail to alarm. The defect could delay critical warnings for patients. Healthcare facilities should stop using the devices immediately and follow recall instructions from Philips or their healthcare provider.
Philips North America recalled 1,913,441 IntelliVue MP30 monitors on October 31, 2025. The devices may fail to alarm, posing a serious risk to patients. Users must stop using the monitors and follow recall instructions immediately.
STRYKER recalled 39,148 NICO Myriad Handpieces sold worldwide due to latex in packaging that could trigger allergic reactions. The latex-containing tape secures components within packaging. Healthcare providers and patients should stop using the device immediately and follow the recall instructions from Stryker.
Olympus Corporation of the Americas recalled 7,803 HX-400U-30 single‑use ligating devices distributed nationwide in the United States. The ligation loop may fail to release or detach. Hospitals and clinics should stop using the device immediately and follow the recall instructions from Olympus or their healthcare providers.
Medicrea recalled 44 units of its IB3D Universal Implant Inserter on October 29, 2025. The device's handle may untread from the shaft, preventing proper rotation of implants. The recall affects states including TN, CA, and TX.
B Braun Medical Inc recalled 2,544 IV administration sets due to risk of backflow from secondary piggyback containers into primary IV lines and inability to prime. The recall covers products used with BBMI Infusomat Space, Outlook, and Vista Basic pumps and distributed worldwide including the US, Canada, Germany, Guatemala and Singapore. Patients should stop using the device immediately and follow
B. Braun Medical recalled 3,120 IV administration sets distributed worldwide to hospitals and clinics. The recall concerns potential backflow of medication from secondary piggyback containers into primary containers and an inability to prime. Hospitals and clinicians should stop using the devices immediately and follow the recall instructions issued by the manufacturer.
B. Braun Medical recalled 66,792 IV Administration Sets sold worldwide through multiple healthcare distributors after reports of backflow and priming occlusion risk. The devices labeled catalog numbers 490241, 490298, and 490360 may allow medication to backflow from piggyback containers into primary lines and may fail to prime. Hospitals and clinicians should stop using immediately and follow the厂
B. Braun Medical recalled 122,232 IV administration sets sold worldwide through multiple medical distributors. The devices have a backflow risk from secondary (piggyback) IV containers into primary IV containers and may fail to prime. Hospitals and clinics should stop using the sets and follow the manufacturer's recall instructions.
B Braun Medical Inc. recalls 36,936 IV administration sets used with Infusomat Space and other pumps worldwide. The recall was announced Oct. 29, 2025 and includes US and international distribution to Canada, Germany, Guatemala and Singapore. The devices may allow backflow of medication from secondary containers into the primary container and cannot be primed. Stop using immediately and follow the
B Braun Medical Inc. recalls 43,900 ADDitIV gravity and pump administration sets. The recall covers catalog numbers V1443, V1447, V1448, and V1484. The issue is backflow of medication from secondary IV containers into primary containers and inability to prime the line. Patients and healthcare providers should stop using these devices immediately and follow recall instructions.
B. Braun Medical has issued an active recall for 45,288 IV administration sets catalog 490412. The devices support gravity and pump-based IV administration with Infusomat Space, Outlook, and Vista Basic Pumps. The recall cites a design defect that can allow backflow from secondary piggyback containers into primary IV lines and prevent priming.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.